CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4/A Open-market buy Director bought 1,000,000 shares at $5.00 ($5,000,000)
- 4 Open-market buy Director bought 1,000,000 shares at $5.00 ($5,000,000)
- 4 Planned sale Chief Financial Officer sold 37,062 shares at $4.75 ($176,119)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Vargeese Chandra sold 10,249 shares at $4.03 ($41,303)
- 4 Open-market sale President and CEO sold 29,400 shares at $4.04 ($118,776)
- 4 Open-market sale Francis Chris sold 10,258 shares at $4.03 ($41,340)
- 4 Open-market sale Chief Financial Officer sold 9,729 shares at $4.04 ($39,305)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 14 · 274 filings